Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.77 USD | -1.69% | +1.23% | +12.71% |
May. 14 | Transcript : Kiniksa Pharmaceuticals, Ltd. Presents at Bank of America Health Care Conference 2024, May-14-2024 10:40 AM | |
Apr. 23 | Kiniksa Pharmaceuticals Q1 Loss Widens, Revenue Rises | MT |
Financials (USD)
Sales 2024 * | 389M | Sales 2025 * | 536M | Capitalization | 1.4B |
---|---|---|---|---|---|
Net income 2024 * | -7M | Net income 2025 * | 42M | EV / Sales 2024 * | 2.98 x |
Net cash position 2024 * | 242M | Net cash position 2025 * | 386M | EV / Sales 2025 * | 1.89 x |
P/E ratio 2024 * |
-186
x | P/E ratio 2025 * |
33.9
x | Employees | 297 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 54.34% |
Latest transcript on Kiniksa Pharmaceuticals, Ltd.
1 day | -1.69% | ||
1 week | +1.23% | ||
Current month | +5.61% | ||
1 month | +17.12% | ||
3 months | -0.85% | ||
6 months | +25.84% | ||
Current year | +12.71% |
Managers | Title | Age | Since |
---|---|---|---|
Eben Tessari
FOU | Founder | 42 | 15-06-30 |
Sanj Patel
CEO | Chief Executive Officer | 54 | 15-06-30 |
Mark Ragosa
DFI | Director of Finance/CFO | 50 | 18-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Felix Baker
BRD | Director/Board Member | 55 | 15-09-30 |
Barry Quart
BRD | Director/Board Member | 67 | 15-09-30 |
Thomas Malley
BRD | Director/Board Member | 55 | 16-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 2 M€ | -.--% | ||
0.05% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - | |
0.03% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 19.77 | -1.69% | 257,669 |
24-05-16 | 20.11 | +0.05% | 303,615 |
24-05-15 | 20.1 | +3.18% | 254,963 |
24-05-14 | 19.48 | -0.51% | 205,113 |
24-05-13 | 19.58 | +0.26% | 193,968 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.71% | 1.4B | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- KNSA Stock